On Tuesday, June 25th, the U.S. Food and Drug Administration ("FDA") responded to the New Drug Application that Acer Therapeutics...

In April 2019, an observational study of vascular EDS was published in the Journal of American College of Cardiology (link). The good news i

As many of you are aware, FightEDS has been working closely with the University of Washington to further research in vascular Ehlers-Danlos

Advice from Benjamin Franklin - how to use prevention and these five tips to better manage vEDS and improve longevity.

Acer Therapeutics Inc., a pharmaceutical company based in Cambridge, MA recently signed an agreement with the Greater Paris University...